Quick Answer
P3 Health Partners Inc. reported Total Revenue of $1.46 billion for the year ending 2025.
- P3 Health Partners Inc. showed a decrease of -2.8% in Total Revenue from 2024 to 2025.
- This data is from P3 Health Partners Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $151.30 million | Q2 2021: $144.59 million | Q3 2021: $156.19 million | Q1 2022: $273.54 million | Q2 2022: $269.45 million | Q3 2022: $248.26 million | Q1 2023: $302.08 million | Q2 2023: $329.09 million | Q3 2023: $288.35 million | Q1 2024: $388.49 million | Q2 2024: $379.16 million | Q3 2024: $362.12 million | Q1 2025: $373.23 million | Q2 2025: $355.79 million | Q3 2025: $345.25 million.
- Over the full 8 years of available data (2019 to 2025), P3 Health Partners Inc.'s Total Revenue has grown by 902.9%.
- Historical annual values: Fiscal year 2025: $1.46 billion | Fiscal year 2024: $1.50 billion | Fiscal year 2023: $1.27 billion | Fiscal year 2022: $1.05 billion | Fiscal year 2021: $58.76 million | Fiscal year 2021: $578.60 million | Fiscal year 2020: $491.06 million | Fiscal year 2019: $145.48 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: